Ultrasound imaging of carotid atherosclerosis in a normal population. The Tromsø study

Norsk Epidemiologi

Volumn 19, Issue 1, 2009, Pages 17-28

  Johnsen, Stein Harald ^a   Mathiesen, Elliesev B ^b  

^a UNIVERSITY HOSPITAL OF NORTH NORWAY   (Norway)

^b UNIVERSITY OF TROMSØ   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGE DISTRIBUTION; AGED; ARTERIAL WALL THICKNESS; ARTICLE; ATHEROSCLEROTIC PLAQUE; BRAIN ISCHEMIA; CARDIOVASCULAR RISK; CAROTID ARTERY DISEASE; CAROTID ARTERY OBSTRUCTION; CAROTID ATHEROSCLEROSIS; COGNITIVE DEFECT; CONTROLLED STUDY; ECHOGRAPHY; FEMALE; FOLLOW UP; HEART INFARCTION; HUMAN; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; NORWAY; POPULATION RESEARCH; PREDICTION; PREVALENCE; REPRODUCIBILITY; RISK FACTOR; SEX DIFFERENCE; SYSTOLIC BLOOD PRESSURE;

EID: 68349110521     PISSN: 08032491     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. Pignoli P, Tremoli E, Poli A, Oreste P, Paoletti R. Intimal plus medial thickness of the arterial wall: a direct measurement with ultrasound imaging. Circulation 1986; 74: 1399-1406.
2. Chambless LE, Heiss G, Folsom AR, Rosamond W, Szklo M, Sharrett AR, Clegg LX. Association of coronary heart disease incidence with carotid arterial wall thickness and major risk factors: the Atherosclerosis Risk in Communities (ARIC) Study, 1987-1993. Am J Epidemiol 1997; 146: 483-494.
3. O'Leary DH, Polak JF, Kronmal RA, Manolio TA, Burke GL, Wolfson SK Jr. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group. N Engl J Med 1999; 340: 14-22.
4. Geroulakos G, O'Gorman D, Nicolaides A, Sheridan D, Elkeles R, Shaper AG. Carotid intima-media thickness: correlation with the British Regional Heart Study risk score. J Intern Med 1994; 235: 431-433.
5. Kieltyka L, Urbina EM, Tang R, Bond MG, Srinivasan SR, Berenson GS. Framingham risk score is related to carotid artery intima-media thickness in both white and black young adults: The Bogalusa Heart Study. Atherosclerosis 2003; 170: 125-130.
6. Touboul PJ, Labreuche J, Vicaut E, Amarenco P. Carotid intima-media thickness, plaques, and Framingham risk score as independent determinants of stroke risk. Stroke 2005; 36: 1741-1745.
7. Grobbee DE, Bots ML. Carotid artery intima-media thickness as an indicator of generalized atherosclerosis. J Intern Med 1994; 236: 567-573.
8. Solberg LA, McGarry PA, Moossy J, Strong JP, Tejada C, Løken AC. Severity of atherosclerosis in cerebral arteries, coronary arteries, and aortas. Ann N Y Acad Sci 1968; 149: 956-973.
9. Wofford JL, Kahl FR, Howard GR, McKinney WM, Toole JF, Crouse JR III. Relation of extent of extracranial carotid artery atherosclerosis as measured by B-mode ultrasound to the extent of coronary atherosclerosis. Arterioscler Thromb 1991; 11: 1786-1794.
10. Bots ML, Hoes AW, Koudstaal PJ, Hofman A, Grobbee DE. Common carotid intima-media thickness and risk of stroke and myocardial infarction: The Rotterdam Study. Circulation 1997; 96: 1432-1437.
11. Chambless LE, Folsom AR, Clegg LX, Sharrett AR, Shahar E, Nieto FJ, Rosamond WD, Evans G. Carotid wall thickness is predictive of incident clinical stroke: the Atherosclerosis Risk in Communities (ARIC) study. Am J Epidemiol 2000; 151: 478-487.
12. Johnsen SH, Mathiesen EB, Joakimsen O, Stensland E, Wilsgaard T, Løchen ML, Njølstad I, Arnesen E. Carotid atherosclerosis is a stronger predictor of myocardial infarction in women than in men: a 6-year follow-up study of 6226 persons: The Tromsø Study. Stroke 2007; 38: 2873-2880.
13. Tabara Y, Kohara K, Nakura J, Miki T. Risk factor-gene interaction in carotid atherosclerosis: effect of gene polymorphisms of renin-angiotensin system. J Hum Genet 2001; 46: 278-284.
14. Chapman CM, Palmer LJ, McQuillan BM, Hung J, Burley J, Hunt C, Thompson PL, Beilby JP. Polymorphisms in the angiotensinogen gene are associated with carotid intimal-medial thickening in females from a community-based population. Atherosclerosis 2001; 159: 209-217.
15. Hegele RA. The pathogenesis of atherosclerosis. Clin Chim Acta 1996; 246: 21-38.
16. Glagov S, Zarins C, Giddens DP, Ku DN. Hemodynamics and atherosclerosis. Insights and perspectives gained from studies of human arteries. Arch Pathol Lab Med 1988; 112: 1018-1031.
17. Joakimsen O, Bønaa KH, Stensland-Bugge E, Jacobsen BK. Age and sex differences in the distribution and ultrasound morphology of carotid atherosclerosis: The Tromsø Study. Arterioscler Thromb Vasc Biol 1999; 19: 3007-3013.
18. Nordestgaard BG, Grønholdt ML, Sillesen H. Echolucent rupture-prone plaques. Curr Opin Lipidol 2003; 14: 505-512.
19. Mathiesen EB, Bønaa KH, Joakimsen O. Echolucent plaques are associated with high risk of ischemic cerebrovascular events in carotid stenosis: The Tromsø Study. Circulation 2001; 103: 2171-2175.
20. Honda O, Sugiyama S, Kugiyama K, Fukushima H, Nakamura S, Koide S, Kojima S, Hirai N, Kawano H, Soejima H, Sakamoto T, Yoshimura M, Ogawa H. Echolucent carotid plaques predict future coronary events in patients with coronary artery disease. J Am Coll Cardiol 2004; 43: 1177-1184.
21. Barnett PA, Spence JD, Manuck SB, Jennings JR. Psychological stress and the progression of carotid artery disease. J Hypertens 1997; 15: 49-55.
22. Spence JD. The importance of distinguishing between diffuse carotid intima medial thickening and focal plaque. Can J Cardiol 2008; 24 (Suppl C): 61C-64C.
23. Spence JD, Eliasziw M, DiCicco M, Hackam DG, Galil R, Lohmann T. Carotid plaque area: a tool for targeting and evaluating vascular preventive therapy. Stroke 2002; 33: 2916-2922.
24. Touboul PJ, Hennerici MG, Meairs S, Adams H, Amarenco P, Bornstein N, et al. Mannheim carotid intimamedia thickness consensus (2004-2006). An update on behalf of the Advisory Board of the 3rd and 4th Watching the Risk Symposium, 13th and 15th European Stroke Conferences, Mannheim, Germany, 2004, and Brussels, Belgium, 2006. Cerebrovasc Dis 2007; 23: 75-80.
25. Salonen R, Seppanen K, Rauramaa R, Salonen JT. Prevalence of carotid atherosclerosis and serum cholesterol levels in eastern Finland. Arteriosclerosis 1988; 8: 788-792.
26. Crouse JR, III, Thompson CJ. An evaluation of methods for imaging and quantifying coronary and carotid lumen stenosis and atherosclerosis. Circulation 1993; 87: II17-II33.
27. Iwamoto T, Shinozaki K, Kiuchi A, Umahara T, Takasaki M. Evaluation of B-mode ultrasonographic images of carotid lesions by computer analysis as compared with visual assessment. J Stroke Cerebrovasc Dis 2003; 12: 59-65.
28. Fosse E, Johnsen SH, Stensland-Bugge E, Joakimsen O, Mathiesen EB, Arnesen E, Njølstad I. Repeated visual and computer-assisted carotid plaque characterization in a longitudinal population-based ultrasound study: The Tromsø Study. Ultrasound Med Biol 2006; 32: 3-11.
29. Stensland-Bugge E, Bønaa KH, Joakimsen O. Reproducibility of ultrasonographically determined intimamedia thickness is dependent on arterial wall thickness. The Tromsø Study. Stroke 1997; 28: 1972-1980.
30. Wendelhag I, Liang Q, Gustavsson T, Wikstrand J. A new automated computerized analyzing system simplifies readings and reduces the variability in ultrasound measurement of intima-media thickness. Stroke 1997; 28: 2195-2200.
31. Joakimsen O, Bønaa KH, Stensland-Bugge E. Reproducibility of ultrasound assessment of carotid plaque occurrence, thickness, and morphology. The Tromsø Study. Stroke 1997; 28: 2201-2207.
32. Mathiesen EB, Joakimsen O, Bønaa KH. Intersonographer reproducibility and intermethod variability of ultrasound measurements of carotid artery stenosis: The Tromsø Study. Cerebrovasc Dis 2000; 10: 207-213.
33. Stensland-Bugge E, Bønaa KH, Joakimsen O. Age and sex differences in the relationship between inherited and lifestyle risk factors and subclinical carotid atherosclerosis: The Tromsø Study. Atherosclerosis 2001; 154: 437-448.
34. Svartberg J, von Muhlen D, Mathiesen E, Joakimsen O, Bønaa KH, Stensland-BuggeE. Low testosterone levels are associated with carotid atherosclerosis in men. J Intern Med 2006; 259: 576-582.
35. Jorde R, Joakimsen O, Stensland E, Mathiesen EB. Lack of significant association between intima-media thickness in the carotid artery and serum TSH level. The Tromsø Study. Thyroid 2008; 18: 21-25.
36. Mathiesen EB, Joakimsen O, Bønaa KH. Prevalence of and risk factors associated with carotid artery stenosis: The Tromsø Study. Cerebrovasc Dis 2001; 12: 44-51.
37. Mathiesen EB, Bønaa KH, Joakimsen O. Low levels of high-density lipoprotein cholesterol are associated with echolucent carotid artery plaques: The Tromsø Study. Stroke 2001; 32: 1960-1965.
38. Johnsen SH, Fosse E, Joakimsen O, Mathiesen EB, Stensland-Bugge E, Njølstad I, Arnesen E. Monocyte count is a predictor of novel plaque formation: a 7-year follow-up study of 2610 persons without carotid plaque at baseline. The Tromsø Study. Stroke 2005; 36: 715-719.
39. Joakimsen O, Bønaa KH, Stensland-Bugge E, Jacobsen BK. Population-based study of age at menopause and ultrasound assessed carotid atherosclerosis: The Tromsø Study. J Clin Epidemiol 2000; 53: 525-530.
40. Notø AT, Mathiesen EB, Brox J, Bjørkegren J, Hansen JB. The ApoC-I content of VLDL particles is associated with plaque size in persons with carotid atherosclerosis. Lipids 2008; 43: 673-679.
41. Halvorsen DS, Karlsen J, Notø AT, Mathiesen EB, Njølstad I, Gutteberg TJ, Vorland LH, Hansen JB. No detectable Chlamydia pneumoniae and cytomegalovirus DNA in leukocytes in subjects with echolucent and echogenic carotid artery plaques. Int J Cardiol 2007; 117: 388-394.
42. Notø AT, Mathiesen EB, Brox J, Bjørkegren J, Hansen JB. Delayed metabolism of postprandial triglyceriderich lipoproteins in subjects with echolucent carotid plaques. Lipids 2008; 43: 353-360.
43. Jørgensen L, Jenssen T, Joakimsen O, Heuch I, Ingebretsen OC, Jacobsen BK. Glycated hemoglobin level is strongly related to the prevalence of carotid artery plaques with high echogenicity in nondiabetic individuals: The Tromsø Study. Circulation 2004; 110: 466-470.
44. Vik A, Mathiesen EB, Notø AT, Sveinbjørnsson B, Brox J, Hansen JB. Serum osteoprotegerin is inversely associated with carotid plaque echogenicity in humans. Atherosclerosis 2007; 191: 128-134.
45. With Notø AT, Bogeberg ME, Amiral J, Vissac AM, Hansen JB. Endothelial dysfunction and systemic inflammation in persons with echolucent carotid plaques. Thromb Haemost 2006; 96: 53-59.
46. With Notø AT, Mathiesen EB, østerud B, Amiral J, Vissac AM, Hansen JB. Increased thrombin generation in persons with echogenic carotid plaques. Thromb Haemost 2008; 99: 602-608.
47. Johnsen SH, Mathiesen EB, Fosse E, Joakimsen O, Stensland-Bugge E, Njølstad I, Arnesen E. Elevated highdensity lipoprotein cholesterol levels are protective against plaque progression: a follow-up study of 1952 persons with carotid atherosclerosis.The Tromsø Study. Circulation 2005; 112: 498-504.
48. Jørgensen L, Jenssen T, Johnsen SH, Mathiesen EB, Heuch I, Joakimsen O, Fosse E, Jacobsen BK. Albuminuria as risk factor for initiation and progression of carotid atherosclerosis in non-diabetic persons: The Tromsø Study. Eur Heart J 2007; 28: 363-369.
49. Kronborg J, Johnsen SH, Njølstad I, Toft I, Eriksen BO, Jenssen T. Proinsulin: insulin and insulin: glucose ratios as predictors of carotid plaque growth: a population-based 7 year follow-up of the Tromsø Study. Diabetologia 2007; 50: 1607-1614.
50. Joakimsen O, Bønaa KH, Mathiesen EB, Stensland-Bugge E, Arnesen E. Prediction of mortality by ultrasound screening of a general population for carotid stenosis: The Tromsø Study. Stroke 2000; 31: 1871-1876.
51. Mathiesen EB, Waterloo K, Joakimsen O, Bakke SJ, Jacobsen EA, Bønaa KH. Reduced neuropsychological test performance in asymptomatic carotid stenosis: The Tromsø Study. Neurology 2004; 62: 695-701.